Status:

COMPLETED

Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate

Lead Sponsor:

Benha University

Conditions:

Magnesium Sulfate - PPHN

Eligibility:

All Genders

1-3 years

Phase:

PHASE2

PHASE3

Brief Summary

we conducted this study to compare between effect of nebulized and intravenous magnesium sulfate (MgSO₄) for better treatment of persistent pulmonary hypertension of neonates with less side effects.

Detailed Description

Persistent pulmonary hypertension of the newborn (PPHN) is a serious syndrome characterized by sustained fetal elevation of pulmonary vascular resistance (PVR) at birth. The syndrome is seen in two of...

Eligibility Criteria

Inclusion

  • Newborns with documented persistent pulmonary hypertension as confirmed by echocardiography.
  • Neonates born at ≥ 35 wk. gestation with a birth weight of 2.5-4 kg
  • Neonates have to be connected to mechanical ventilation with an oxygenation index (OI) \>30 on two occasions at least 15 min apart.
  • The echocardiogram had to show a predominant right-to-left or bidirectional shunt (through ductus arteriosus and/or foramen oval) and/or tricuspid regurgitant jet with a pressure gradient ≥ 2/3 of the systemic systolic blood pressure.

Exclusion

  • Infants of parents who refuse to give informed consent.
  • Infants of mothers who receive magnesium sulfate within 48 h before labor.
  • Congenital heart diseases other than patent ductus arteriosus (PDA) and foramen ovale.
  • Major congenital anomalies, including congenital diaphragmatic hernia and lung hypoplasia.
  • Prior need for cardiopulmonary resuscitation
  • Mean arterial blood pressure (MABP) \< 35 mmHg despite therapy with volume infusions and vasoactive inotropes.
  • Impaired kidney function; and prior administration of pulmonary vasodilators or prior administration of surfactant.

Key Trial Info

Start Date :

October 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 28 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06603766

Start Date

October 1 2021

End Date

September 28 2023

Last Update

February 5 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pediatrics Department, Faculty of Medicine, Benha University.

Benha, Egypt., Egypt